News

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...
The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.